Abstract
Precise quantification of human cells in preclinical animal models by a sensitive and specific approach is warranted. The probe-based quantitative PCR (qPCR) assay as a sensitive and swift approach is suitable for the quantification of human cells by targeting human-specific DNA sequences. In this study, we developed an efficient qPCR assay targeting human-specific DNA in ST6GALNAC3 (termed ST6GAL-qPCR) for the quantification of human cells in preclinical animal models. ST6GAL-qPCR probe was synthesized with FAM and non-fluorescent quencher-minor groove binder conjugated to the 5′ and 3′ end of the probe, respectively. Genomic DNA from human, rhesus monkeys, cynomolgus monkeys, New Zealand White rabbits, SD rats, C57BL/6, and BALB/c mice were utilized for analyzing the specificity and sensitivity of the ST6GAL-qPCR assay. The ST6GAL-qPCR assay targeted human-specific DNA was cloned to pUCM-T vector and released by EcoR I/Hind III digestion for generating a calibration curve. Cell mixing experiment was performed to validate the ST6GAL-qPCR assay by analysis of 0.1%, 0.01%, and 0.001% of human leukocytes mixed with murine thymocytes. The ST6GAL-qPCR assay detected human DNA rather than DNA from the tested animal species. The amplification efficiency of the ST6GAL-qPCR assay was 93% and the linearity of calibration curve was R2 = 0.999. The ST6GAL-qPCR assay detected as low as 5 copies of human-specific DNA and is efficient to specially amplify as low as 30-pg human DNA in the presence of 1 μg of DNA from the tested species, respectively. The ST6GAL-qPCR assay was able to quantify as low as 0.01% of human leukocytes within murine thymocytes. This ST6GAL-qPCR assay can be used as an efficient approach for the quantification of human cells in preclinical animal models.
Similar content being viewed by others
Data availability
The data underlying this article will be shared on reasonable request to the corresponding author.
References
El-Kadiry, A. E., Rafei, M., & Shammaa, R. (2021). Cell therapy: Types, regulation, and clinical benefits. Front Med (Lausanne), 8, 756029.
Bastien, J. P., Minguy, A., Dave, V., & Roy, D. C. (2019). Cellular therapy approaches harnessing the power of the immune system for personalized cancer treatment. Seminars in Immunology, 42, 101306.
Wang, L. L., Janes, M. E., Kumbhojkar, N., Kapate, N., Clegg, J. R., Prakash, S., Heavey, M. K., Zhao, Z., Anselmo, A. C., & Mitragotri, S. (2021). Cell therapies in the clinic. Bioeng Transl Med 6(2), e10214.
Campbell, A., Brieva, T., Raviv, L., Rowley, J., Niss, K., Brandwein, H., Oh, S., & Karnieli, O. (2015). Concise Review: Process development considerations for cell therapy. Stem Cells Transl Med 4(10), 1155-1163.
Osada, N. (2015). Genetic diversity in humans and non-human primates and its evolutionary consequences. Genes and Genetic Systems, 90(3), 133–145.
Harding, J., Roberts, R. M., & Mirochnitchenko, O. (2013). Large animal models for stem cell therapy. Stem Cell Research and Therapy, 4(2), 23.
Yamamoto, S., Ding, N., Matsumoto, S. I., & Hirabayashi, H. (2021). Highly specific, quantitative polymerase chain reaction probe for the quantification of human cells in cynomolgus monkeys. Drug Metab Pharmacokinet 36, 100359.
Song, P., Xie, Z., Guo, L., Wang, C., Xie, W., & Wu, Y. (2012). Human genome-specific real-time PCR method for sensitive detection and reproducible quantitation of human cells in mice. Stem Cell Rev Rep 8(4),1155–1162.
Kline, M. C., Romsos, E. L., & Duewer, D. L. (2016). Evaluating digital PCR for the quantification of human genomic DNA: Accessible amplifiable targets. Analytical Chemistry, 88(4), 2132–2139.
Prigent, J., Herrero, A., Ambroise, J., Smets, F., Deblandre, G. A., & Sokal, E. M. (2015). Human progenitor cell quantification after xenotransplantation in rat and mouse models by a sensitive qPCR Assay. Cell Transplant 24(8), 1639–1652.
Funakoshi, K, Bagheri, M., Zhou, M., Suzuki, R., Abe, H., & Akashi, H. (2017). Highly sensitive and specific Alu-based quantification of human cells among rodent cells. Scientific reports 7(1), 13202.
Suntsova, M. V., & Buzdin, A. A. (2020). Differences between human and chimpanzee genomes and their implications in gene expression, protein functions and biochemical properties of the two species. BMC Genomics, 21(Suppl 7), 535.
Lander, E.S., Linton, L.M., Birren, B., Nusbaum, C., Zody, M. C. & ... (2001). Initial sequencing and analysis of the human genome. Nature 409(6822), 860–921.
McBlane, J. W., Phul, P., & Sharpe, M. (2018). Preclinical development of cell-based products: A European regulatory science perspective. Pharmaceutical Research, 35(8), 165.
Smithson, M., Irwin, R., Williams, G., Alexander, K. L., Smythies, L. E., Nearing, M., McLeod, M. C., Al Diffalha, S., Bellis, S. L., & Hardiman, K. M. (2022). Sialyltransferase ST6GAL-1 mediates resistance to chemoradiation in rectal cancer. J Biol Chem 298(3), 101594.
Liu, X., Liu, Y., Ma, Y., Gong, Y., Liu, Q., Sun, W., & Guo, H. (2021). Establishment of patient-specific induced pluripotent stem cell line SDUBMSi009-A from a patient with X-linked Lowe syndrome. Stem Cell Res 51, 102171.
Kent, W. J. (2002). BLAT—The BLAST-like alignment tool. Genome Research, 12(4), 656–664.
Chimpanzee, S., & Analysis, C. (2005). Initial sequence of the chimpanzee genome and comparison with the human genome. Nature, 437(7055), 69–87.
Piovesan, A., Pelleri, M.C., Antonaros, F., Strippoli, P., Caracausi, M., & Vitale, L. (2019). On the length, weight and GC content of the human genome. BMC Res Notes 12(1), 106.
Soejima, M., Hiroshige, K., Yoshimoto, J., & Koda, Y. (2012). Selective quantification of human DNA by real-time PCR of FOXP2. Forensic Sci Int Genet 6(4), 447–451.
Zong, C., Lu, S., Chapman, A. R., & Xie, X. S. (2012). Genome-wide detection of single-nucleotide and copy-number variations of a single human cell. Science 338(6114), 1622–1626.
Hiroshige, K., Soejima, M., Nishioka, T., Kamimura, S., & Koda, Y. (2009). Simple and sensitive method for identification of human DNA by allele-specific polymerase chain reaction of FOXP2. J Forensic Sci 54(4), 857–861.
Atkins, J. T., George, G. C., Hess, K., Marcelo-Lewis, K. L., Yuan, Y., Borthakur, G., Khozin, S., LoRusso, P., & Hong, D. S. (2020) Pre-clinical animal models are poor predictors of human toxicities in phase 1 oncology clinical trials. Br J Cancer 123(10), 1496–1501.
Van Norman, G. A. (2019). Limitations of animal studies for predicting toxicity in clinical trials: Is it time to rethink our current approach? JACC Basic to Translational Science, 4(7), 845–854.
Chua, D., Low, Z. S., Cheam, G. X., Ng, A. S., & Tan, N. S. (2022). Utility of human relevant preclinical animal models in navigating NAFLD to MAFLD paradigm. Int J Mol Sci 23(23).
Shigeto, J., Ichiki, T., Nii, T., Konno, K., Nakanishi, Y., & Sugiyama, D. (2018). Preclinical toxicity studies for regenerative medicine in Japan. Clin Ther 40(11), 1813–1822.
Walker, J. A., Kilroy, G. E., Xing, J., Shewale, J., Sinha, S. K., & Batzer, M. A. (2003). Human DNA quantitation using Alu element-based polymerase chain reaction. Anal Biochem 315(1), 122–128.
Walker, J. A., Hedges, D. J., Perodeau, B. P., Landry, K. E., Stoilova, N., Laborde, M. E., Shewale, J., Sinha, S. K., & Batzer, M. A. (2005). Multiplex polymerase chain reaction for simultaneous quantitation of human nuclear, mitochondrial, and male Y-chromosome DNA: application in human identification. Anal Biochem 337(1), 89–97.
Acknowledgements
This work was supported by the National Natural Science Foundation of China (Grant No. 82171791), Xuzhou Science and Technology Program (KC20089), the Youth Innovation Team Grant and the Starting Grant by Xuzhou Medical University (Grant No. D2018009), the Postgraduate Research and Practice Innovation Program of Jiangsu Province, China (KYCX21_2638 and KYCX22_2875), Jiangsu Training Program of Innovation and Entrepreneurship for Undergraduates (202210313005Z), and the Special Science and Technology Project on Life and Health by Nanjing Municipal Bureau of Science and Technology (202205009).
Author information
Authors and Affiliations
Contributions
JR, KL, LH, RY, YL, SW, XC, LJ, TL, and BH performed the experiments. JR, KL, and LH performed data analysis. SZ and XZ contributed the collection of human and monkey samples. HL and HW conceived and supervised the study. HL and HW prepared the figures and wrote the manuscript.
Corresponding authors
Ethics declarations
Conflict of interest
The authors have no conflicts of interest in relation to this work.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
12033_2024_1115_MOESM2_ESM.pdf
Supplementary file2 (PDF 274 kb) DNA alignment of human-specific DNA in ST6GALNAC3 with ST6GALNAC3 genomic DNA of rhesus and cynomolgus monkeys. A 1460 bp of DNA fragment in human ST6GALNAC3 was aligned with rhesus (A) and cynomolgus (B) ST6GALNAC3 genomic DNA
12033_2024_1115_MOESM3_ESM.pdf
Supplementary file3 (PDF 475 kb) Validation of the ST6GAL-qPCR products by DNA sequencing. The PCR products of the ST6GAL-qPCR was cloned to pUCM-T vectors and subsequently analyzed by DNA sequencing
12033_2024_1115_MOESM4_ESM.jpg
Supplementary file4 (JPG 77 kb) Analysis of human genomic DNA by the ST6GAL-qPCR assay. A representative amplification plot of the ST6GAL-qPCR analysis of genomic DNA (1–10 ng) of 48 individuals
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Ren, J., Liu, K., Hu, L. et al. An Efficient Probe-Based Quantitative PCR Assay Targeting Human-Specific DNA in ST6GALNAC3 for the Quantification of Human Cells in Preclinical Animal Models. Mol Biotechnol (2024). https://doi.org/10.1007/s12033-024-01115-8
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12033-024-01115-8